Patents by Inventor Christian Berthou

Christian Berthou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides used for treating cancers and, in particular, chronic lymphoid leukaemia
    Patent number: 9745357
    Abstract: The invention relates to the A1 peptide of the sequence RRKYGRDFLLRF, as well as to certain variants thereof, for treating cancers, in particular malignant hematopoietic diseases, and more particularly for treating chronic lymphoid leukaemia.
    Type: Grant
    Filed: March 5, 2010
    Date of Patent: August 29, 2017
    Assignees: Centre National de la Recherche Scientifique, Centre Hospitalier Universitaire de Brest, Universite de Bretagne Occidentale, Universite Pierre et Marie Curie (Paris 6)
    Inventors: Bertrand Cosson, Hussam Saad, Patrick Cormier, Christian Berthou, Mirjam Czjzek
  • Compositions containing antibodies for treating CD5+ HLA-DR+ B or T cell related diseases
    Patent number: 8679500
    Abstract: The present invention relates to compositions containing antibodies for treating CD5+ HLA-DR+ B OR T cell related diseases such as B or T cell malignances (leukaemia and lymphoma), autoimmune diseases and T cell related diseases as transplantation and graft rejection.
    Type: Grant
    Filed: May 14, 2010
    Date of Patent: March 25, 2014
    Assignees: Institute National de la Sante et de la Recherche Medicale (INSERM), Universite de Bretagne Occidentale, Centre National de la Recherche Scientifique (CNRS)
    Inventors: Laurence Boumsell, Christian Berthou, Karine Lester, Severine Loisel, Martine Cerruti
  • Use of purine derivatives for the manufacture of a medicament
    Patent number: 8431583
    Abstract: At least one compound of following formula I: in which: X is C or N, Y is CH3 or OH, and Z is H or CH3, or one of its pharmaceutically acceptable salts, hydrates, esters or isomers, for use in the manufacture of a medicament to treat pathologies in which an imbalance between cell division and apoptosis is involved.
    Type: Grant
    Filed: September 12, 2008
    Date of Patent: April 30, 2013
    Assignees: Centre National de la Recherche Scientifique, Universite de Rennes 1, Universite Paris Descartes, Universite de Bretagne Occidentale, Centre Hospitalier Universitaire de Brest
    Inventors: Laurent Meijer, Karima Bettayeb, Hervé Galons, Nassima Oumata, Christian Berthou, Karine Lester
  • Peptides Used for Treating Cancers and, in Particular, Chronic Lymphoid Leukaemia
    Publication number: 20120172315
    Abstract: The invention relates to the A1 peptide of the sequence RRKYGRDFLLRF, as well as to certain variants thereof, for treating cancers, in particular malignant hematopoietic diseases, and more particularly for treating chronic lymphoid leukaemia.
    Type: Application
    Filed: March 5, 2010
    Publication date: July 5, 2012
    Inventors: Bertrand Cosson, Hussam Saad, Patrick Cormier, Christian Berthou, Mirjam Czjzek
  • COMPOSITIONS CONTAINING ANTIBODIES FOR TREATING CD5+HLA-DR+B OR T CELL RELATED DISEASES
    Publication number: 20120121598
    Abstract: The present invention relates to compositions containing antibodies for treating CD5+ HLA-DR+ B OR T cell related diseases such as B or T cell malignances (leukaemia and lymphoma), autoimmune diseases and T cell related diseases as transplantation and graft rejection.
    Type: Application
    Filed: May 14, 2010
    Publication date: May 17, 2012
    Inventors: Laurence Boumsell, Christian Berthou, Karine Lester, Severine Loisel, Martine Cerruti
  • USE OF PURINE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT
    Publication number: 20100311768
    Abstract: The invention relates to the use of purine derivatives in the manufacture of a medicament for treating pathological conditions in which an imbalance between cell division and apoptosis is involved, and more particularly in which excessive apoptosis is responsible for the pathological condition. According to the invention, a purine derivative of formula I is used. The invention finds use in the pharmaceutical field.
    Type: Application
    Filed: September 12, 2008
    Publication date: December 9, 2010
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE RENNES 1, UNIVERSITE PARIS DESCARTES, UNIVERSITE DE BRETAGNE OCCIDENTALE, CENTRE HOSPITALIER UNIVERSITAIRE DE BREST
    Inventors: Laurent Meijer, Karima Bettayeb, Herve Galons, Nassima Oumata, Christian Berthou, Karine Lester
  • Antibody or Antibody Fragment Coupled with an Immunogenic Agent
    Publication number: 20080292645
    Abstract: An immunogenic conjugate includes a target cell-specific circulating molecule and at least one immunogenic agent, the immunogenic agent being coupled by any appropriate means with the circulating molecule. Also described is a method for preparing the immunogenic conjugate and its use for treating cancers or autoimmune diseases.
    Type: Application
    Filed: May 24, 2006
    Publication date: November 27, 2008
    Inventors: Anthony Courtois, Christian Berthou, Anne Loussouarn, Jean Guezennec, Claire Boisset, Stephanie Gac-Breton